Paper Details

  1. Home
  2. Paper Details

Antibiotics for the treatment of dysentery in children.

Author: BlackRobert E, MunosMelinda, TraaBeatrix S, WalkerChrista L Fischer

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Ciprofloxacin, ceftriaxone, and pivmecillinam, antibiotics recommended by the World Health Organization (WHO) for dysentery in children, are effective in reducing clinical and bacteriological signs and symptoms of dysentery.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Ciprofloxacin, ceftriaxone and pivmecillinam are the antibiotics currently recommended by the World Health Organization (WHO) for the treatment of dysentery in children; yet there have been no reviews of the clinical effectiveness of these antibiotics in recent years. METHODS: We review...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845863/

データ提供：米国国立医学図書館（NLM）

A Desert Oasis for Dysentery: Ciprofloxacin, Ceftriaxone and Pivmecillinam

The field of pediatric infectious diseases is a vast and challenging desert, where finding effective treatments for common ailments like dysentery can be a true oasis. This study embarked on a journey to explore the effectiveness of three widely used antibiotics: ciprofloxacin, ceftriaxone, and pivmecillinam, in treating dysentery in children living in developing countries. The researchers meticulously reviewed available literature, analyzing data on treatment failure, bacteriological failure, and relapse rates. They found that these antibiotics exhibited a remarkable cure rate of over 99%, effectively alleviating the clinical and bacteriological symptoms of dysentery. This discovery serves as a beacon of hope, offering a reliable treatment option for a disease that plagues many children in the developing world.

A Promising Solution for a Common Problem

This study, based on a rigorous analysis of existing data, provides strong evidence for the effectiveness of these antibiotics. The high cure rate demonstrated across various studies suggests that ciprofloxacin, ceftriaxone, and pivmecillinam offer a valuable tool for controlling dysentery in children. Their efficacy in reducing clinical and bacteriological symptoms is a significant step towards reducing the mortality associated with dysentery.

Staying Hydrated: A Crucial Step

As Dr. Camel, I would always recommend staying hydrated. Especially in cases of dysentery, dehydration can be a serious threat. These antibiotics are effective for fighting dysentery, but adequate fluid intake is vital for recovery. It's like navigating a desert journey: you need to replenish your resources to stay strong.

Dr.Camel's Conclusion

This study shines a light on the importance of rigorous research in tackling infectious diseases. The effectiveness of these antibiotics in reducing the impact of dysentery offers a glimmer of hope for the health of children in developing countries. The results are a testament to the power of scientific investigation in finding solutions to critical healthcare challenges.

Date :
  1. Date Completed 2010-04-27
  2. Date Revised 2022-08-27
Further Info :

Pubmed ID

20348130

DOI: Digital Object Identifier

PMC2845863

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.